VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Clinical trial NCT00083187 · COMPLETED

Trial details

NCT number: NCT00083187
Sponsor: Vion Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2005-11-01
Primary completion: 2007-01-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.